March 27, 2017
The Japanese Cabinet on March 24 approved a plan to raise the Pharmaceuticals and Medical Devices Agency’s (PMDA) review fees for drugs, medical devices, and regenerative medicine-based products, as well as GMP inspection fees, which will take effect in FY2017...read more